Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects

Authors not listed

BioSpectrum Inc · 2015

Dysbiosis Human Randomized controlled trial

Abstract

This randomized, double-blind, split-face controlled study was conducted to evaluate the anti-wrinkle efficacy and safety of a Syringic acid-containing emulsion in healthy female subjects. The test product was an emulsion containing 2% Synox, a Syringic acid-containing ingredient, while the control product was an emulsion without Synox. Participants applied the test and control products to opposite sides of the face according to random allocation for 12 weeks. Skin wrinkle-related parameters were evaluated at baseline and after 4, 8, and 12 weeks of product use using visual assessment, replica-based instrumental measurement, and subject questionnaires. Skin safety was monitored throughout the study period.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2015). A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects. <em>BioSpectrum Inc</em>. https://clinicaltrials.gov/study/NCT07850817

Vancouver

Anonymous. A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects. BioSpectrum Inc. 2015.

BibTeX

@misc{anon2015ARando, title = {A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects}, author = {Anonymous}, journal = {BioSpectrum Inc}, year = {2015}, }